Yüklüyor......
A case of checkpoint inhibitor-induced celiac disease
BACKGROUND: Immune checkpoint inhibitors (ICIs) have now become standard of care treatment for many malignancies. ICIs are associated with unique immune mediated adverse events (irAEs) due to dysregulation of immune activation. As treatment with ICIs is becoming more common, rare irAEs are also bein...
Kaydedildi:
| Yayımlandı: | J Immunother Cancer |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683380/ https://ncbi.nlm.nih.gov/pubmed/31383006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0694-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|